Bruker introduces NMR test for Covid risk assessment
PhenoRisk PACS RuO enables quantitative multiplexed testing for the early detection of clinically well-characterised risk markers.
Germany
Latest in
Germany
Wallaby acquires German company phenox for $543m
The merged company could become a leader in offering various neurovascular technologies and solutions globally.
Fresenius Kabi to acquire medical technology company Ivenix
Ivenix's infusion system was introduced last year after receiving US Food and Drug Administration (FDA) clearance.
Synlab and OncoDNA partner to offer cancer therapy testing in Germany
The collaboration will provide access to pan-cancer biomarker testing for oncologists.
Vela Diagnostics launches new panels to detect cancer biomarkers
The new panels can detect RNA and DNA cancer biomarkers from formalin-fixed paraffin-embedded tissue specimens.
Evonik to expand 3D-printable biomaterials portfolio with PEEK filament
The PEEK filament can be processed in common extrusion-based 3D printing technologies, such as fused filament fabrication.
Qiagen reports 20% increase in full year 2021 net sales
Austria, the UK, Italy, Turkey and Switzerland delivered significant gains during the period.
Mainz Biomed to assess mRNA biomarkers integration into cancer test
The ColoFuture study will assess the mRNA biomarkers’ effectiveness to improve the technical profile of the ColoAlert test.